Mucin-interacting proteins

From function to therapeutics

Shantibhusan Senapati, Srustidhar Das, Surinder Kumar Batra

Research output: Contribution to journalReview article

91 Citations (Scopus)

Abstract

Mucins are high molecular weight glycoproteins that are involved in regulating diverse cellular activities both in normal and pathological conditions. Mucin activity and localization is mediated by several molecular mechanisms, including discrete interactions with other proteins. An understanding of the biochemistry behind the known interactions between mucins and other proteins, coupled with an appreciation of their pathophysiological significance, can lend insight into the development of novel therapeutic agents. Indeed, a recent study demonstrated that a cell permeable inhibitor, PMIP, that disrupts the MUC1-EGFR interaction, is effective in killing breast cancer cells in vitro and in tumor models.

Original languageEnglish (US)
Pages (from-to)236-245
Number of pages10
JournalTrends in Biochemical Sciences
Volume35
Issue number4
DOIs
StatePublished - Apr 1 2010

Fingerprint

Mucins
Biochemistry
Proteins
Tumors
Glycoproteins
Therapeutics
Molecular Weight
Molecular weight
Cells
Breast Neoplasms
Neoplasms

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Mucin-interacting proteins : From function to therapeutics. / Senapati, Shantibhusan; Das, Srustidhar; Batra, Surinder Kumar.

In: Trends in Biochemical Sciences, Vol. 35, No. 4, 01.04.2010, p. 236-245.

Research output: Contribution to journalReview article

Senapati, Shantibhusan ; Das, Srustidhar ; Batra, Surinder Kumar. / Mucin-interacting proteins : From function to therapeutics. In: Trends in Biochemical Sciences. 2010 ; Vol. 35, No. 4. pp. 236-245.
@article{ebf548f4ab7c49d7ad385ae30706ec9b,
title = "Mucin-interacting proteins: From function to therapeutics",
abstract = "Mucins are high molecular weight glycoproteins that are involved in regulating diverse cellular activities both in normal and pathological conditions. Mucin activity and localization is mediated by several molecular mechanisms, including discrete interactions with other proteins. An understanding of the biochemistry behind the known interactions between mucins and other proteins, coupled with an appreciation of their pathophysiological significance, can lend insight into the development of novel therapeutic agents. Indeed, a recent study demonstrated that a cell permeable inhibitor, PMIP, that disrupts the MUC1-EGFR interaction, is effective in killing breast cancer cells in vitro and in tumor models.",
author = "Shantibhusan Senapati and Srustidhar Das and Batra, {Surinder Kumar}",
year = "2010",
month = "4",
day = "1",
doi = "10.1016/j.tibs.2009.10.003",
language = "English (US)",
volume = "35",
pages = "236--245",
journal = "Trends in Biochemical Sciences",
issn = "0376-5067",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Mucin-interacting proteins

T2 - From function to therapeutics

AU - Senapati, Shantibhusan

AU - Das, Srustidhar

AU - Batra, Surinder Kumar

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Mucins are high molecular weight glycoproteins that are involved in regulating diverse cellular activities both in normal and pathological conditions. Mucin activity and localization is mediated by several molecular mechanisms, including discrete interactions with other proteins. An understanding of the biochemistry behind the known interactions between mucins and other proteins, coupled with an appreciation of their pathophysiological significance, can lend insight into the development of novel therapeutic agents. Indeed, a recent study demonstrated that a cell permeable inhibitor, PMIP, that disrupts the MUC1-EGFR interaction, is effective in killing breast cancer cells in vitro and in tumor models.

AB - Mucins are high molecular weight glycoproteins that are involved in regulating diverse cellular activities both in normal and pathological conditions. Mucin activity and localization is mediated by several molecular mechanisms, including discrete interactions with other proteins. An understanding of the biochemistry behind the known interactions between mucins and other proteins, coupled with an appreciation of their pathophysiological significance, can lend insight into the development of novel therapeutic agents. Indeed, a recent study demonstrated that a cell permeable inhibitor, PMIP, that disrupts the MUC1-EGFR interaction, is effective in killing breast cancer cells in vitro and in tumor models.

UR - http://www.scopus.com/inward/record.url?scp=77951019810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951019810&partnerID=8YFLogxK

U2 - 10.1016/j.tibs.2009.10.003

DO - 10.1016/j.tibs.2009.10.003

M3 - Review article

VL - 35

SP - 236

EP - 245

JO - Trends in Biochemical Sciences

JF - Trends in Biochemical Sciences

SN - 0376-5067

IS - 4

ER -